房颤患者长期抗凝接受门诊全膝关节置换术:一项回顾性匹配队列研究
本回顾性匹配队列研究基于保险理赔数据库,纳入2010年1月至2022年4月接受门诊全膝关节置换术的房颤患者,比较长期使用华法林(N=4,396)或直接口服抗凝药(DOAC,N=5,383)者与1:1匹配对照的术后并发症。结果显示抗凝患者医疗并发症发生率更高、手术并发症发生率更低,作者认为长期抗凝患者可考虑门诊全膝关节置换术,但应充分告知相关医疗风险。
要点
- 华法林组肺栓塞发生率高于匹配对照(1.1% vs 0.2%,P<0.001),TKA翻修率低于对照(0.1% vs 0.4%,P=0.003)。
- DOAC组肺炎(1.4% vs 0.6%,P<0.001)和心肌梗死(3.2% vs 1.5%,P<0.001)发生率高于匹配对照。
- DOAC组伤口裂开(0.1% vs 0.5%,P<0.001)、关节感染(0.4% vs 0.9%,P=0.002)和TKA翻修(0.1% vs 0.4%,P=0.002)发生率低于匹配对照。
核心结论
- 房颤患者长期抗凝接受门诊TKA的医疗并发症发生率高于匹配对照,手术并发症发生率低于匹配对照。
- 作者认为长期抗凝患者可考虑门诊TKA,但应充分告知相关医疗风险。
研究设计与样本
- 回顾性匹配队列研究,查询保险理赔数据库识别2010年1月至2022年4月接受门诊TKA的患者。
- 房颤患者中,华法林组N=4,396,DOAC组N=5,383,均按1:1匹配对照,抗凝处方至少填写30天。
- 华法林队列平均年龄70岁(范围51至84岁),女性占47.9%;DOAC队列平均年龄70岁,女性占49.2%。
- 比较术后30天医疗并发症和90天手术并发症。
主要发现
- 华法林组肺栓塞发生率1.1%,匹配对照0.2%(P<0.001)。
- 华法林组TKA翻修率0.1%,匹配对照0.4%(P=0.003)。
- DOAC组肺炎发生率1.4%,匹配对照0.6%(P<0.001);心肌梗死发生率3.2%,匹配对照1.5%(P<0.001)。
- DOAC组伤口裂开发生率0.1%,匹配对照0.5%(P<0.001);关节感染发生率0.4%,匹配对照0.9%(P=0.002);TKA翻修率0.1%,匹配对照0.4%(P=0.002)。
临床怎么用
- 作者认为,长期抗凝的房颤患者可考虑接受门诊TKA,但应就相关医疗风险进行充分告知。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who have atrial fibrillation frequently require long-term anticoagulation with warfarin or a direct-acting oral anticoagulant (DOAC), such as apixaban or rivaroxaban, to avoid vascular complications. However, the impact of anticoagulant use on postoperative complications following total knee arthroplasty (TKA) in an outpatient setting has not been thoroughly elucidated. The purpose of this study was to examine the impact of anticoagulant use on early postoperative complications among atrial fibrillation patients undergoing outpatient TKA. METHODS: An insurance claims database was queried to identify all patients who underwent outpatient TKA between January 2010 and April 2022. There were two cohorts of patients, with associated 1:1 matched controls, who had atrial fibrillation and filled a prescription of either warfarin (N = 4,396) or DOAC (N = 5,383) for at least 30 days. The mean age was 70 years (range, 51 to 84), and 47.9% were women in the warfarin cohort, while the mean age was 70 years and 49.2% were women in the DOAC cohort. Postoperative 30-day medical and 90-day surgical complications were subsequently compared. RESULTS: Patients on warfarin had a higher incidence of pulmonary embolism (1.1 versus 0.2%, P < 0.001) and a lower incidence of TKA revision (0.1 versus 0.4%, P = 0.003) than matched controls. Similarly, patients on DOACs exhibited a higher incidence of pneumonia (1.4 versus 0.6%, P < 0.001) and myocardial infarction (3.2 versus 1.5%, P < 0.001) and a lower incidence of wound dehiscence (0.1 versus 0.5%, P < 0.001), joint infection (0.4 versus 0.9%, P = 0.002), and TKA revision (0.1 versus 0.4%, P = 0.002) than matched controls. CONCLUSIONS: Atrial fibrillation patients on long-term anticoagulants undergoing outpatient TKA experience higher rates of medical complications and lower rates of surgical complications than matched controls. Thus, patients on long-term anticoagulants may be considered for outpatient TKA but should be counseled appropriately on associated medical risks.
引用
- Singh M, Balmaceno-Criss M, Liu J, et al. Chronic Anticoagulation in Patients Who Have Atrial Fibrillation Undergoing Outpatient Total Knee Arthroplasty: A Retrospective Matched Cohort Study. J Arthroplasty. 2024. PMID: 39357687. doi:10.1016/j.arth.2024.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。